Strs Ohio Mirum Pharmaceuticals, Inc. Transaction History

Strs Ohio

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	BUY	$18.42 - $27.5 $11,052 - $16,500	600 Added 6.25%	10,200 $198,000
Q3 2021 Oct 22, 2021	SELL	$13.95 - $20.18 $55,800 - $80,720	-4,000 Reduced 29.41%	9,600 $191,000
Q2 2021 Jul 26, 2021	BUY	$15.84 - $20.6 $20,592 - $26,780	1,300 Added 10.57%	13,600 $235,000
Q3 2020 Dec 14, 2020	BUY	$18.4 - $26.59 $213,439 - $308,444	11,600 Added 1657.14%	12,300 $237,000
Q4 2019 Jan 24, 2020	BUY	$6.84 - $25.9 $4,788 - $18,130	700 New	700 $17,000

208

54M

64.1K

117K

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.84B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.